.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Covington
McKesson
Cerilliant
Healthtrust
Federal Trade Commission
Daiichi Sankyo
Dow
US Department of Justice
Cantor Fitzgerald

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076402

« Back to Dashboard
NDA 076402 describes BENAZEPRIL HYDROCHLORIDE, which is a drug marketed by Sandoz, Teva, Aurobindo Pharma, Prinston Inc, Amneal Pharms, Apotex Inc, Mylan, Ivax Sub Teva Pharms, Sun Pharm Inds Ltd, Zydus Pharms Usa, Actavis Labs Fl Inc, Genpharm, and Mylan Pharms Inc, and is included in nineteen NDAs. It is available from forty suppliers. Additional details are available on the BENAZEPRIL HYDROCHLORIDE profile page.

The generic ingredient in BENAZEPRIL HYDROCHLORIDE is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.

Summary for NDA: 076402

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 076402

Suppliers and Packaging for NDA: 076402

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENAZEPRIL HYDROCHLORIDE
benazepril hydrochloride
TABLET;ORAL 076402 ANDA Eon Labs, Inc. 0185-0053 0185-0053-01 100 TABLET, FILM COATED in 1 BOTTLE (0185-0053-01)
BENAZEPRIL HYDROCHLORIDE
benazepril hydrochloride
TABLET;ORAL 076402 ANDA Eon Labs, Inc. 0185-0053 0185-0053-05 500 TABLET, FILM COATED in 1 BOTTLE (0185-0053-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Feb 11, 2004TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Feb 11, 2004TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Feb 11, 2004TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Colorcon
US Department of Justice
Harvard Business School
Daiichi Sankyo
QuintilesIMS
Cantor Fitzgerald
Cerilliant
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot